A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

NCT07308548 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

NAFLD (Non-alcoholic Fatty Liver Disease)

Interventions

DRUG: HP515 10 mg Tablet
DRUG: Placebo of HP515 10 mg Tablet
DRUG: HP515 20 mg Tablet
DRUG: Placebo of HP515 20mg Tablet

Sponsor

Hinova Pharmaceuticals Inc.